COVID-19 and the Radiology Department: What We Know So Far
- PDF / 1,149,211 Bytes
- 7 Pages / 595.276 x 790.866 pts Page_size
- 76 Downloads / 203 Views
COVID-19
COVID-19 and the Radiology Department: What We Know So Far Sanya Vermani 1 & Aditya Kaushal 2 & Jessica Kaushal 3 Accepted: 24 September 2020 # Springer Nature Switzerland AG 2020
Abstract COVID-19 is a global healthcare pandemic that is now growing through nations across the world. The role of radiology is crucial, and a variety of guidelines have been published regarding the role of imaging. These aim to protect healthcare workers (HCWs) and the general public from exposure, while preserving critical radiology operations and conserving personal protective equipment (PPE) and other critical care resources during the COVID-19 pandemic. Fleischner Society published guidelines on indications of imaging various settings. These guidelines take into account resource availability, pre-test probability, degree of symptoms and risk factors, which is crucial for decision-making regarding need and indications of imaging. Mitigating steps and alternative approaches should be considered to provide the best care for patients while protecting all HCWs. Owing to overlap of COVID-19 imaging findings with other pathologies, standardized reporting acquires importance for risk assessment and effective communication of suspicious findings. RSNA followed by Dutch Radiological Society (NVvR) have published guidelines on standardized CT reporting for COVID-19, which show excellent inter-observer variability. Standardized reporting can provide guidance and confidence to radiologists as well as increased clarity to physicians through reduced reporting variability. The article discusses the published recommendations and aims to make radiologists aware of the protocols and guidelines that need to be followed in this ongoing public health crisis for effective patient care while protecting HCWs and conserving resources. Keywords COVID-19 . Radiology . Imaging . Pandemics . Coronavirus
Introduction In and around the Huanan seafood market in Wuhan, located in Hubei province in China, a cluster of cases with unexplained low respiratory infections with few developing acute respiratory distress syndrome and respiratory failure were detected in December 2019 [1, 2]. On 31 December 2019, these were reported to the WHO Office in China. Published literature can trace the onset of symptomatic people back to early December 2019. Such first cases (n = 29) were labelled as “pneumonia of unknown aetiology” since they were unable to classify the causative agent. An ambitious outbreak investigation system was
* Aditya Kaushal [email protected] 1
All India Institute of Medical Sciences, Virbhadra Road, Rishikesh, India
2
Post Graduate Institute of Medical Education and Research, Sector-12, Chandigarh, India
3
Government Medical College, Circular Road, Amritsar, India
coordinated by the Chinese Center for Disease Control and Prevention (CDC). The aetiology of this disease has been traced to a new coronavirus (CoV) virus. The pathogen was identified on January 7, 2020, as a novel form of virus from the coronavirus family and was tempora
Data Loading...
